Lee Jeonghwan, Baek Seon Ha, Ahn Shin Young, Chin Ho Jun, Na Ki Young, Chae Dong-Wan, Kim Sejoong
Department of Internal Medicine, Hallym University Hangang Sacred Heart Hospital, Seoul, Korea.
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
PLoS One. 2016 Dec 1;11(12):e0167038. doi: 10.1371/journal.pone.0167038. eCollection 2016.
The significance of minimal increases in serum creatinine below the levels indicative of the acute kidney injury (AKI) stage is not well established. We aimed to investigate the influence of pre-stage AKI (pre-AKI) on clinical outcomes. We enrolled a total of 21,261 patients who were admitted to the Seoul National University Bundang Hospital from January 1, 2013 to December 31, 2013. Pre-AKI was defined as a 25-50% increase in peak serum creatinine levels from baseline levels during the hospital stay. In total, 5.4% of the patients had pre-AKI during admission. The patients with pre-AKI were predominantly female (55.0%) and had a lower body weight and lower baseline levels of serum creatinine (0.63 ± 0.18 mg/dl) than the patients with AKI and the patients without AKI (P < 0.001). The patients with pre-AKI had a higher prevalence of diabetes mellitus (25.1%) and malignancy (32.6%). The adjusted hazard ratio of in-hospital mortality for pre-AKI was 2.112 [95% confidence interval (CI), 1.143 to 3.903]. In addition, patients with pre-AKI had an increased length of stay (7.7 ± 9.7 days in patients without AKI, 11.4 ± 11.4 days in patients with pre-AKI, P < 0.001) and increased medical costs (4,061 ± 4,318 USD in patients without AKI, 4,966 ± 5,099 USD in patients with pre-AKI, P < 0.001) during admission. The adjusted hazard ratio of all-cause mortality for pre-AKI during the follow-up period of 2.0 ± 0.6 years was 1.473 (95% CI, 1.228 to 1.684). Although the adjusted hazard ratio of pre-AKI for overall mortality was not significant among the patients admitted to the surgery department or who underwent surgery, pre-AKI was significantly associated with mortality among the non-surgical patients (adjusted HR 1.542 [95% CI, 1.330 to 1.787]) and the patients admitted to the medical department (adjusted HR 1.384 [95% CI, 1.153 to 1.662]). Pre-AKI is associated with increased mortality, longer hospital stay, and increased medical costs during admission. More attention should be paid to the clinical significance of pre-AKI.
血清肌酐水平出现低于急性肾损伤(AKI)阶段指标的微小升高,其意义尚未明确。我们旨在研究AKI前期(pre-AKI)对临床结局的影响。我们纳入了2013年1月1日至2013年12月31日期间入住首尔国立大学盆唐医院的总共21261例患者。Pre-AKI定义为住院期间血清肌酐峰值水平较基线水平升高25% - 50%。总共有5.4%的患者在入院期间出现pre-AKI。与AKI患者和无AKI患者相比,pre-AKI患者以女性为主(55.0%),体重更低,血清肌酐基线水平更低(0.63±0.18mg/dl)(P<0.001)。Pre-AKI患者糖尿病(25.1%)和恶性肿瘤(32.6%)的患病率更高。Pre-AKI患者院内死亡的校正风险比为2.112[95%置信区间(CI),1.143至3.903]。此外,pre-AKI患者住院时间延长(无AKI患者为7.7±9.7天,pre-AKI患者为11.4±11.4天,P<0.001),住院期间医疗费用增加(无AKI患者为4061±4318美元,pre-AKI患者为4966±5099美元,P<0.001)。在2.0±0.6年的随访期内,pre-AKI患者全因死亡的校正风险比为1.473(95%CI,1.228至1.684)。尽管在外科住院患者或接受手术的患者中,pre-AKI对总体死亡率的校正风险比不显著,但pre-AKI与非手术患者的死亡率显著相关(校正HR 1.542[95%CI,1.330至1.787])以及内科住院患者的死亡率显著相关(校正HR 1.384[95%CI,1.153至1.662])。Pre-AKI与住院期间死亡率增加、住院时间延长和医疗费用增加相关。应更加关注pre-AKI的临床意义。